Sandu Pharmaceuticals (524703.BO) Stock Price

Sandu Pharmaceuticals Price

CLOSED
37.90INR+0.09 (+0.24 %)
Market closed

Over the last 7 years Sandu Pharmaceuticals grew revenue by 4.6% annually, reaching 671.92 M INR. Earnings per share have grown at 10.6% per year over the last 7 years. For Sandu Pharmaceuticals, the net margin of 2.3% is broadly stable versus 1.9% a few years ago. At today's price the dividend yield works out to roughly 2.11%. The payout ratio is around 50% of earnings. The dividend has grown at 12.5% per year over the past 4 years. The stock trades about 26% above its 52-week low.

Sandu Pharmaceuticals stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Sandu Pharmaceuticals over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sandu Pharmaceuticals stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sandu Pharmaceuticals's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Sandu Pharmaceuticals Stock Price History
DateSandu Pharmaceuticals Price
8/21/202637.90 INR
8/20/202637.81 INR
8/19/202638.00 INR
8/18/202638.00 INR
8/17/202637.51 INR
8/14/202636.96 INR
8/13/202636.27 INR
8/12/202639.29 INR
8/11/202639.46 INR
8/10/202639.80 INR
8/7/202639.61 INR
8/6/202638.48 INR
8/5/202639.80 INR
8/4/202639.23 INR
8/3/202640.69 INR
7/30/202639.50 INR
7/29/202638.40 INR
7/28/202638.00 INR
7/27/202639.30 INR
7/24/202639.29 INR
7/23/202641.00 INR
7/22/202641.03 INR
7/21/202639.55 INR
7/20/202638.16 INR
7/17/202638.16 INR
7/16/202639.62 INR
7/15/202641.00 INR
7/14/202640.51 INR
7/13/202640.91 INR
7/10/202641.00 INR
7/9/202640.57 INR
7/8/202641.39 INR
7/7/202640.66 INR
7/6/202641.92 INR
7/3/202641.59 INR
7/2/202641.35 INR
7/1/202641.35 INR
6/30/202641.00 INR
6/29/202641.01 INR
6/25/202641.45 INR
6/24/202641.51 INR
6/23/202640.94 INR
6/22/202642.14 INR
6/19/202642.77 INR
6/18/202642.22 INR
6/17/202642.90 INR
6/16/202643.10 INR
6/15/202643.51 INR
6/12/202641.61 INR
6/11/202642.94 INR
6/10/202641.18 INR
6/9/202642.07 INR
6/8/202642.03 INR
6/5/202642.50 INR
6/4/202643.60 INR
6/3/202642.59 INR
6/2/202643.04 INR
6/1/202644.09 INR
5/29/202642.00 INR
5/28/202644.13 INR
5/27/202644.13 INR
5/26/202644.14 INR
5/25/202639.96 INR
5/22/202639.00 INR
5/21/202639.33 INR
5/20/202638.42 INR
5/19/202638.68 INR
5/18/202637.75 INR
5/15/202638.39 INR
5/14/202637.19 INR
5/13/202637.48 INR
5/12/202638.46 INR
5/11/202639.02 INR
5/8/202639.32 INR
5/7/202640.03 INR
5/6/202641.90 INR
5/5/202642.11 INR
5/4/202642.99 INR
4/30/202644.00 INR
4/29/202644.90 INR
4/28/202646.11 INR
4/27/202646.12 INR
4/24/202643.80 INR
4/23/202643.64 INR
4/22/202643.95 INR
4/21/202638.10 INR
4/20/202638.80 INR
4/17/202638.45 INR
4/16/202637.95 INR
4/15/202637.99 INR
4/13/202637.00 INR
4/10/202636.49 INR
4/9/202636.26 INR
4/8/202637.90 INR
4/7/202635.80 INR
4/6/202635.19 INR
4/2/202632.42 INR
4/1/202633.69 INR
3/30/202630.10 INR
3/27/202633.36 INR
3/25/202634.00 INR
3/24/202633.20 INR
3/23/202634.30 INR
3/20/202634.46 INR
3/19/202634.00 INR
3/18/202632.05 INR
3/17/202633.80 INR
3/16/202633.50 INR
3/13/202632.90 INR
3/12/202634.25 INR
3/11/202635.35 INR
3/10/202635.00 INR
3/9/202633.90 INR
3/6/202634.76 INR
3/5/202634.80 INR
3/4/202634.56 INR
3/2/202635.60 INR
2/27/202635.00 INR
2/26/202635.05 INR
2/25/202635.00 INR
2/24/202635.40 INR
2/23/202636.25 INR
2/20/202636.74 INR
2/19/202636.85 INR
2/18/202635.80 INR
2/17/202634.32 INR
2/16/202635.12 INR
2/13/202634.80 INR
2/12/202634.50 INR
2/11/202635.25 INR
2/10/202637.50 INR
2/9/202636.00 INR
2/6/202633.61 INR
2/5/202633.80 INR
2/4/202633.90 INR
2/3/202634.00 INR
2/2/202634.70 INR
2/1/202634.00 INR
1/30/202634.40 INR
1/29/202634.29 INR
1/28/202633.20 INR
1/27/202633.80 INR
1/23/202633.50 INR
1/22/202633.23 INR
1/21/202631.30 INR
1/20/202637.87 INR
1/19/202638.72 INR
1/16/202639.50 INR
1/14/202639.01 INR
1/13/202640.34 INR
1/12/202638.06 INR
1/9/202640.15 INR
1/8/202640.74 INR
1/7/202640.30 INR
1/6/202637.85 INR
1/5/202637.70 INR
1/2/202639.25 INR
1/1/202637.45 INR
12/31/202537.36 INR
12/30/202538.74 INR
12/29/202538.03 INR
12/26/202538.50 INR
12/24/202538.10 INR
12/23/202538.45 INR
12/22/202538.95 INR
12/19/202538.00 INR
12/18/202538.98 INR
12/17/202538.99 INR
12/16/202539.00 INR
12/15/202539.30 INR
12/12/202539.50 INR
12/11/202538.50 INR
12/10/202538.20 INR
12/9/202538.01 INR
12/8/202539.49 INR
12/5/202539.50 INR
12/4/202540.40 INR
12/3/202539.50 INR
12/2/202539.50 INR
12/1/202539.71 INR
11/28/202537.80 INR
11/27/202538.49 INR
11/26/202538.16 INR
11/25/202537.30 INR
11/24/202540.49 INR
11/21/202540.00 INR
11/20/202542.00 INR
11/19/202540.70 INR
11/18/202541.78 INR
11/17/202542.80 INR
11/14/202543.50 INR
11/13/202543.50 INR
11/12/202544.00 INR
11/11/202543.14 INR
11/10/202543.20 INR
11/7/202543.70 INR
11/6/202543.00 INR
11/4/202544.25 INR
11/3/202544.10 INR
10/31/202544.30 INR
10/30/202544.00 INR
10/29/202543.81 INR
10/28/202543.49 INR
10/27/202544.81 INR
10/24/202544.10 INR
10/23/202544.50 INR
10/21/202544.32 INR
10/20/202544.32 INR
10/17/202544.00 INR
10/16/202544.10 INR
10/15/202544.96 INR
10/14/202544.05 INR
10/13/202544.79 INR
10/10/202544.90 INR
10/9/202543.76 INR
10/8/202544.67 INR
10/7/202544.53 INR
10/6/202544.50 INR
10/3/202546.95 INR
10/1/202546.16 INR
9/30/202546.64 INR
9/29/202546.87 INR
9/26/202546.34 INR
9/25/202547.95 INR
9/24/202547.99 INR
9/23/202547.06 INR
9/22/202547.33 INR
9/19/202547.21 INR
9/18/202547.94 INR
9/17/202548.51 INR
9/16/202549.00 INR
9/15/202547.40 INR
9/12/202546.76 INR
9/11/202547.50 INR
9/10/202547.50 INR
9/9/202548.47 INR
9/8/202547.35 INR
9/5/202548.00 INR
9/4/202548.98 INR
9/3/202548.01 INR
9/2/202548.00 INR
9/1/202547.16 INR
8/29/202548.99 INR
8/28/202548.90 INR
8/26/202549.20 INR
8/25/202549.21 INR
Access this data via the Eulerpool API
Get Free API Key

Sandu Pharmaceuticals Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
491.60 M INR
18.64 M INR
5.62 M INR
Jan 1, 2019
494.25 M INR
14.58 M INR
6.69 M INR
Jan 1, 2020
483.68 M INR
9.03 M INR
7.20 M INR
Jan 1, 2021
587.55 M INR
16.02 M INR
10.92 M INR
Jan 1, 2022
655.01 M INR
23.44 M INR
15.89 M INR
Jan 1, 2023
653.49 M INR
19.69 M INR
15.21 M INR
Jan 1, 2024
672.81 M INR
17.12 M INR
14.61 M INR
Jan 1, 2025
671.92 M INR
20.92 M INR
15.49 M INR

Sandu Pharmaceuticals Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 24, 2026, 1:44 AM
 
REVENUEM INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM INR
EBITM INR
EBIT MARGIN%
NET INCOMEM INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
20182019202020212022202320242025
491.00494.00483.00587.00655.00653.00672.00671.00
–0.61-2.2321.5311.58-0.312.91-0.15
41.9648.7948.0341.2345.3452.2251.6452.16
206.00241.00232.00242.00297.00341.00347.00350.00
18.0014.009.0016.0023.0019.0017.0020.00
3.672.831.862.733.512.912.532.98
5.006.007.0010.0015.0015.0014.0015.00
–20.0016.6742.8650.00–-6.677.14
–––0.500.750.750.800.80
––––50.00–6.67–
7.087.087.087.098.509.439.669.66
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Sandu Pharmaceuticals generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sandu Pharmaceuticals retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sandu Pharmaceuticals's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Sandu Pharmaceuticals has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sandu Pharmaceuticals's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Sandu Pharmaceuticals stock margins

The Sandu Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sandu Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sandu Pharmaceuticals.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
41.95 %
3.79 %
1.14 %
Jan 1, 2019
48.79 %
2.95 %
1.35 %
Jan 1, 2020
48.08 %
1.87 %
1.49 %
Jan 1, 2021
41.28 %
2.73 %
1.86 %
Jan 1, 2022
45.43 %
3.58 %
2.43 %
Jan 1, 2023
52.27 %
3.01 %
2.33 %
Jan 1, 2024
51.59 %
2.55 %
2.17 %
Jan 1, 2025
52.22 %
3.11 %
2.31 %

Sandu Pharmaceuticals Stock Revenue, EBIT, Earnings per Share

The Sandu Pharmaceuticals earnings per share therefore indicates how much revenue Sandu Pharmaceuticals has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
69.43 INR
2.63 INR
0.79 INR
Jan 1, 2019
69.80 INR
2.06 INR
0.94 INR
Jan 1, 2020
68.31 INR
1.28 INR
1.02 INR
Jan 1, 2021
82.89 INR
2.26 INR
1.54 INR
Jan 1, 2022
77.03 INR
2.76 INR
1.87 INR
Jan 1, 2023
69.28 INR
2.09 INR
1.61 INR
Jan 1, 2024
69.64 INR
1.77 INR
1.51 INR
Jan 1, 2025
69.55 INR
2.16 INR
1.60 INR

Sandu Pharmaceuticals business model & stock analysis

Sandu Pharmaceuticals Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Sandu Pharmaceuticals historical P/E ratio, EBIT multiple, and P/S ratio

Sandu Pharmaceuticals annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Sandu Pharmaceuticals shares outstanding

The number of shares of Sandu Pharmaceuticals was 9.66 M in 2025. This indicates how many shares Sandu Pharmaceuticals is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
7.08 M Stocks
Jan 1, 2019
7.08 M Stocks
Jan 1, 2020
7.08 M Stocks
Jan 1, 2021
7.09 M Stocks
Jan 1, 2022
8.50 M Stocks
Jan 1, 2023
9.43 M Stocks
Jan 1, 2024
9.66 M Stocks
Jan 1, 2025
9.66 M Stocks

Sandu Pharmaceuticals Dividend History

5 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.80INR 0.0%1×
Sep 18, 20250.80INR 0.0%1/1
20240.80INR↑ 6.7%1×
20230.75INR 0.0%1×
20220.75INR↑ 50.0%1×
20210.50INR—1×

Sandu Pharmaceuticals dividend history and estimates

In 2025, Sandu Pharmaceuticals paid a dividend amounting to 0.80 INR. Dividend means that Sandu Pharmaceuticals distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021 (e)
0.00 INR
0.50 INR
Jan 1, 2022
0.75 INR
0.00 INR
Jan 1, 2023
0.75 INR
0.00 INR
Jan 1, 2024
0.80 INR
0.00 INR
Jan 1, 2025
0.80 INR
0.00 INR

Sandu Pharmaceuticals dividend payout ratio

In 2025, Sandu Pharmaceuticals had a payout ratio of 49.90%. The payout ratio indicates the percentage of the company's profits that Sandu Pharmaceuticals distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
49.77 %
Jan 1, 2019
49.77 %
Jan 1, 2020
49.77 %
Jan 1, 2021
32.44 %
Jan 1, 2022
40.13 %
Jan 1, 2023
46.53 %
Jan 1, 2024
52.89 %
Jan 1, 2025
49.90 %
Price targets and forecasts for Sandu Pharmaceuticals are not yet available.

Sandu Pharmaceuticals shareholder structure

% Name
14.37570%
Sandu (Umesh B)
Sandu (Umesh B)
14.16931%
Sandu (Shashank Bhaskar)
Sandu (Shashank Bhaskar)
7.62940%
Sandu (Jayshree Bhaskar)
Sandu (Jayshree Bhaskar)
5.63075%
Sanmark Realty & Finance Pvt. Ltd.
Sanmark Realty & Finance Pvt. Ltd.
5.11576%
Akshath Finvest And Properties Pvt Ltd
Akshath Finvest And Properties Pvt Ltd
4.71527%
Neelambar Leasing and Finvest Pvt. Ltd.
Neelambar Leasing and Finvest Pvt. Ltd.

Sandu Pharmaceuticals Executives and Management Board

8 members · avg. age 62 · 25 % women

SS

Shri. Umesh Sandu (56)

Managing Director, Executive Director · since 2013

7.12 M INR

Management

PM

Mrs. Pratika Mhambray

Compliance Officer, Company Secretary

332,318.00 INR
VK

Mr. Vijay Kajrekar

Chief Financial Officer

–

Board of Directors

SS

Shri. Shashank Sandu (58)

Non-Executive Non-Independent Director

47,500.00 INR
SV

Shri. Balram Viswanathan (56)

Non-Executive Independent Chairman of the Board

–
SS

Smt. Jayshree Sandu (81)

Non-Executive Non-Independent Women Director

–
SK

Shri. Ajit Kantak (65)

Additional Non-Executive Independent Director

–
SK

Shri. Vijay Kottapalli (56)

Additional Non-Executive Independent Director

–

Frequently asked questions about Sandu Pharmaceuticals

Converted at the current exchange rate, the Sandu Pharmaceuticals share trades at 0.34 EUR (37.90 INR).

No history available for Sandu Pharmaceuticals.

The revenue cannot currently be calculated for Sandu Pharmaceuticals.

The profit cannot currently be calculated for Sandu Pharmaceuticals.

The P/E ratio cannot be calculated for Sandu Pharmaceuticals at the moment.

The P/S cannot be calculated for Sandu Pharmaceuticals currently.

The Eulerpool Quality Score for Sandu Pharmaceuticals is 1/10.

The ISIN of Sandu Pharmaceuticals is INE751D01014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Sandu Pharmaceuticals is 524703.BO. The ticker symbol is used to trade Sandu Pharmaceuticals shares on the stock exchange.

Over the past 12 months, Sandu Pharmaceuticals paid a dividend of 0.80 INR . This corresponds to a dividend yield of about 2.11 %. For the coming 12 months, Sandu Pharmaceuticals is expected to pay a dividend of 0.80 INR.

The current dividend yield of Sandu Pharmaceuticals is 2.11 %.

Sandu Pharmaceuticals pays a dividend, distributed in the months of , , , .

Sandu Pharmaceuticals paid dividends every year for the past 5 years.

For the upcoming 12 months, dividends amounting to 0.80 INR are expected. This corresponds to a dividend yield of 2.11 %.

Sandu Pharmaceuticals is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of Sandu Pharmaceuticals from amounting to 0.8 INR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Sandu Pharmaceuticals distributed 0.75 INR as dividends.

The dividends of Sandu Pharmaceuticals are distributed in INR.

All fundamentals and in-depth analysis of Sandu Pharmaceuticals

Our stock analysis for Sandu Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sandu Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Revenue→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Net Income→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals P/E→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals P/S→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals EBIT→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Dividend→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Directors Dealings→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Stocks→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Market capitalization→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Debt→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Liabilities→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Equity→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals AAQS→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Employees→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals ROE→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals ROA→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals ROCE→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals News→
Sandu Pharmaceuticals Stock
Sandu Pharmaceuticals Analyst Price Targets→

Non-cyclical consumption Stocks

SanfordSan-A CoSanjiang Shopping Club CoSan Miguel Food and BeverageSano Brunos EnterprisesSamyang HoldingsSanquan Food CoSamyang FoodsSanstarSamyangSanwaria ConsumerSampre NutritionsAll Stocks A–Z →